These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14042043)

  • 1. A comparative evaluation of a new oral cholecystographic agent bilopaque with orabilex.
    JUDKINS MP BILLIMORIA PE; DOTTER CT
    Am J Roentgenol Radium Ther Nucl Med; 1963 Apr; 89():859-63. PubMed ID: 14042043
    [No Abstract]   [Full Text] [Related]  

  • 2. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 3. RENAL TOXICITY OF ORAL CHOLECYSTOGRAPHIC MEDIA. BUNAMIODYL SODIUM AND IOPANOIC ACID.
    WENNBERG JE; OKUN R; HINMAN EJ; NORTHCUTT RC; GRIEP RJ; WALKER WG
    JAMA; 1963 Nov; 186():461-7. PubMed ID: 14085024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 5. CLINICAL COMPARISON OF THREE CHOLECYSTOGRAPHIC MEDIA.
    HURLEY DJ; FEORE DR
    J Can Assoc Radiol; 1963 Dec; 14():187-90. PubMed ID: 14086129
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of a new cholecystographic agent: WIN 8851-2 (Bilopaque).
    POLLACK S
    J Okla State Med Assoc; 1963 Jan; 56():13-7. PubMed ID: 13971989
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative clinical evaluation of a new oral cholecystographic medium, orabilex with telepaque.
    O'LACO JP; WILCOX WA
    Wis Med J; 1960 Apr; 59():249-51. PubMed ID: 14428090
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque).
    Wishart DL; Dotter CT
    Am J Roentgenol Radium Ther Nucl Med; 1973 Oct; 119(2):429-32. PubMed ID: 4748234
    [No Abstract]   [Full Text] [Related]  

  • 9. BILOPAQUE: A NEW CHOLECYSTOGRAPHIC MEDIUM.
    BURHENNE HJ
    Radiology; 1963 Oct; 81():629-31. PubMed ID: 14078329
    [No Abstract]   [Full Text] [Related]  

  • 10. A preliminary clinical evaluation of a new cholecystographic medium, bilopaque.
    BENISEK GJ; GUNN JA
    Am J Roentgenol Radium Ther Nucl Med; 1962 Oct; 88():792-6. PubMed ID: 13867240
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder.
    Han SY; Witten DM
    Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280
    [No Abstract]   [Full Text] [Related]  

  • 12. AN INVESTIGATION ON OPAQUE MEDIA FOR CHOLECYSTOGRAPHY.
    O'SHEA JJ
    Radiography; 1964 May; 30():135-6. PubMed ID: 14145069
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholecystography with orabilex (a new cholecystographic dye).
    KLEIN MM
    W V Med J; 1960 Mar; 56():102-3. PubMed ID: 14409694
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind study of oral cholecystographic media: orabilex and telepaque.
    MORGAN LA; PARKS RE
    Radiology; 1960 Mar; 74():436-41. PubMed ID: 14424118
    [No Abstract]   [Full Text] [Related]  

  • 15. Conjugated sodium tyropanoate (Bilopaque) in the bowel: significance of its presence or absence after first-dose oral cholecystography.
    Muhletaler CA; Gerlock AJ; Avant GR
    Radiology; 1981 Nov; 141(2):311-6. PubMed ID: 7291552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystalluria potential of cholecystographic agents.
    NELSON E
    N Engl J Med; 1963 May; 268():1236-7. PubMed ID: 13938034
    [No Abstract]   [Full Text] [Related]  

  • 17. ACUTE RENAL FAILURE FOLLOWING ORAL CHOLECYSTOGRAPHY: A UNIQUE NEPHROGRAPHIC EFFECT.
    HARROW BR; SLOANE JA
    Am J Med Sci; 1965 Jan; 249():26-35. PubMed ID: 14254825
    [No Abstract]   [Full Text] [Related]  

  • 18. ETIOLOGY OF SERIOUS REACTIONS TO ORAL CHOLECYSTOGRAPHY.
    SANEN FJ; MYERSON RM; TEPLICK JG
    Arch Intern Med; 1964 Feb; 113():241-7. PubMed ID: 14090392
    [No Abstract]   [Full Text] [Related]  

  • 19. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of bunamiodyl (Orabilex) and iopanoic acid (Telepaque): a clinical report on 200 cases.
    FARRELL TE; WELDON WV
    South Med J; 1961 Jan; 54():54-6. PubMed ID: 13698272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.